
Hayden Ansinelli
@ansinelliradonc
Father, Husband, Radiation Oncologist at @AZOncology, Tucson AZ. Views my own.
ID: 1576266506693799936
01-10-2022 17:43:29
31 Tweet
73 Followers
207 Following


March is #ColorectalCancerAwarenessMonth! Thanks to Meteorologist Carrigan Chauvin for inviting me to discuss the importance of colorectal cancer screening this morning š„ CW39 Houston Methodist MD #radonc cw39.com/cw39/tips-fromā¦

Amazing work in Neurosurgery Publications from Intl Radiosurgery Research Foundation led by Raj Singh, MD, outcomes after SRS for GI brain Mets. journals.lww.com/neurosurgery/Aā¦


The great ā¦Raj Singh, MDā© sharing his study utilizing #SBRT in extracranial sarcoma metastases at #RSS2023 ā¦the Radiosurgery Societyā© The Ohio State University Wexner Medical Centerā© ā¦VCU Massey Comprehensive Cancer Centerā© ā¦VCU Radiation Oncology Residencyā©


#WeAreTheABS #AllThingsBrachy #ThisIsBrachytherapy #WeImprovePatientOutcomes. Thank you to our members for making #ABSBrachy23 a huge success. DrKamrava Peter Rossi Brett Cox, MD Junzo Chino Bethany Anderson Neil K. Taunk Andrew Farach, MD Lauren Andring Arash Naghavi Chirag Shah


Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option. awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ IASLC MD Anderson Cancer Center The Lancet Albert Koong, MD PhD Stephen V Liu, MD


itās always gratifying to see your trainee Phil pifer now extending state of the art kelowna hybrid brachytherapy in the state of West Virginia Hima Bindu Musunuru Andrew Keller American Brachy DrKamrava Varian


Sad to see that IMRT is not covered by UnitedHealthcare Ask UnitedHealthcare for limited stage small cell lung cancer, particularly given encouraging findings regarding dose escalation vs. SoC from two Phase II trials, known association of heart dose on survival, and National Comprehensive Cancer Network (NCCN) recommending IMRT over 3D-CRT.

EviCore By Evernorth Anthem Blue Cross and Blue Shield denying IMRT over 3D for a young breast cancer in a patient < 40 - 3D plan not meeting constraints, plan sent. Denied. Staff told there is NO option for a āpeerā-to-peer or reconsideration. !? This should be a no brainer. Do better for my patient EviCore By Evernorth



For anyone interested in the #300in10 mini-fellowship to develop expertise in #brachytherapy this is a must listen! š Thanks to Manuj Agarwal and Rebecca Krc for highlighting the work of the Houston Methodist MD #Bteam! Now 12 training sites in the šŗšø&šØš¦ americanbrachytherapy.org/resources/fellā¦

Great to catch up with fellow ā¦Marshall School of Medicineā© ā18 grad and #RadOnc ā¦Hayden Ansinelliā© while in AZ! Go Herd!






First hybrid brachytherapy in Guatemala American Brachy DrKamrava Andrew Keller Scott Glaser
